| Metric | FY 2024 | Prior Q | FY 2023 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $240M | — | $212M | — | 13.1% |
| Op. Income | $31M | — | $29M | — | 7.5% |
| Gross Margin | 57.3% | — | 62.0% | — | -4.6pp |
| Net Margin | 10.2% | — | 11.0% | — | -0.8pp |
| EPS (Diluted) | $1.06 | — | $1.00 | — | 6.0% |
| Free Cash Flow | $29M | — | $37M | — | -22.0% |
| Item | Amount |
|---|---|
| REVENUE | $240M |
| Cost of Revenue | $102M |
| GROSS PROFIT | $137M |
| R&D Expenses | $0 |
| Selling & Marketing | $3M |
| General & Administrative | $64M |
| SG&A Expenses | $67M |
| Other Expenses | $40M |
| Operating Expenses | $107M |
| Cost & Expenses | $209M |
| OPERATING INCOME | $31M |
| Interest Income | $221M |
| Interest Expense | $107M |
| Other Income/Expenses | $0 |
| INCOME BEFORE TAX | $31M |
| Income Tax Expense | $6M |
| Net Income from Continuing Ops | $25M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $25M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $25M |
| D&A | $7M |
| EBIT | $31M |
| EBITDA | $38M |
| EPS | $1 |
| EPS Diluted | $1 |
| Item | Amount |
|---|---|
| REVENUE | $240M |
| Cost of Revenue | $102M |
| GROSS PROFIT | $137M |
| R&D Expenses | $0 |
| Selling & Marketing | $3M |
| General & Administrative | $64M |
| SG&A Expenses | $67M |
| Other Expenses | $40M |
| Operating Expenses | $107M |
| Cost & Expenses | $209M |
| OPERATING INCOME | $31M |
| Interest Income | $221M |
| Interest Expense | $107M |
| Other Income/Expenses | $0 |
| INCOME BEFORE TAX | $31M |
| Income Tax Expense | $6M |
| Net Income from Continuing Ops | $25M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $25M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $25M |
| D&A | $7M |
| EBIT | $31M |
| EBITDA | $38M |
| EPS | $1 |
| EPS Diluted | $1 |
| Item | Amount |
|---|---|
| Net Income | $25M |
| Depreciation & Amortization | $7M |
| Stock-Based Compensation | $2M |
| Deferred Income Tax | $3M |
| Other Non-Cash Items | -$1M |
| Change in Working Capital | $2M |
| OPERATING CASH FLOW | $37M |
| Capital Expenditure | -$8M |
| Acquisitions (Net) | $0 |
| Purchases of Investments | -$25M |
| Sales/Maturities of Investments | $81M |
| Other Investing Activities | -$117M |
| NET CASH FROM INVESTING | -$68M |
| Net Debt Issuance | -$323M |
| Common Stock Repurchased | $0 |
| Common Dividends Paid | $0 |
| Other Financing Activities | $432M |
| NET CASH FROM FINANCING | $108M |
| FREE CASH FLOW | $29M |
| Net Change in Cash | $77M |
| Item | Amount |
|---|---|
| Cash & Equivalents | $131M |
| Short-Term Investments | $655M |
| Net Receivables | $63M |
| Inventory | $0 |
| Other Current Assets | $0 |
| TOTAL CURRENT ASSETS | $850M |
| PP&E (Net) | $74M |
| Goodwill | $0 |
| Intangible Assets | $0 |
| Long-Term Investments | $3.6B |
| Tax Assets | $0 |
| Other Non-Current Assets | $176M |
| TOTAL NON-CURRENT ASSETS | $3.8B |
| TOTAL ASSETS | $4.7B |
| Account Payables | $0 |
| Short-Term Debt | $0 |
| Deferred Revenue | $0 |
| Other Current Liabilities | $4.2B |
| TOTAL CURRENT LIABILITIES | $4.2B |
| Long-Term Debt | $70M |
| Deferred Revenue NC | $0 |
| Deferred Tax Liabilities | $0 |
| Other Non-Current Liabilities | $51M |
| TOTAL NON-CURRENT LIABILITIES | $121M |
| TOTAL LIABILITIES | $4.3B |
| Common Stock | $23M |
| Additional Paid-In Capital | $92M |
| Retained Earnings | $334M |
| Treasury Stock | $0 |
| Accum. Other Comp. Income | -$65M |
| Other Equity | $0 |
| TOTAL STOCKHOLDERS' EQUITY | $384M |
| Minority Interest | $0 |
| TOTAL EQUITY | $384M |
| TOTAL LIABILITIES & EQUITY | $4.7B |
| Total Debt | $70M |
| Net Debt | -$61M |
